Russia's health ministry appoints chief clinical pharmacologist
This article was originally published in Scrip
Russia's ministry of health and social development has appointed Professor Vladimir Petrov chief clinical pharmacologist. He is currently head of the medical university in Volgograd, central Russia. His objectives in the new post include updating reimbursement lists for all state programmes and improving the organisation of side-effect reporting and the prescribing of the most effective medicines in hospitals through the mandatory recruitment of clinical pharmacologists.
You may also be interested in...
Poland's president, Bronislaw Komorowski, has signed a reimbursement bill into the law which will come into force on 1 January.
In the past two years, most multinational pharmaceutical companies announced plans to create production facilities in Russia. They had been ignoring such an opportunity for years, and there were reasons for that. They included risks to investments, administrative barriers, unclear regulations assuming various interpretations and corruption.
Russia's president Dmitriy Medvedev has requested that his government start talks with the US and the EU on the mutual recognition of clinical trial results (including paediatric trials) and prepare proposals for corresponding amendments of existing regulations.